表紙
市場調査レポート

B細胞慢性リンパ性白血病:世界の治験レビュー

B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

発行 GlobalData 商品コード 296844
出版日 ページ情報 英文 265 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
B細胞慢性リンパ性白血病:世界の治験レビュー B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016
出版日: 2016年06月29日 ページ情報: 英文 265 Pages
概要

当レポートでは、B細胞慢性リンパ性白血病に関する臨床研究の最新動向について分析し、疾患の概要を初め、主な先進国・新興国における治験の状況、地域・フェーズ(相)・段階別の進行状況、被験者の募集状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • B細胞慢性リンパ性白血病
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国の治験件数
    • 欧州の主要5ヶ国の治験件数
    • 北米の主要国の治験件数
    • 中東・アフリカの主要国の治験件数
    • 中南米の主要国の治験件数

G7諸国での治験件数:腫瘍全体に対する比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:腫瘍全体に対する比率

E7諸国での治験件数:フェーズ(相)別

E7諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

各フェーズでの試験完了状況

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

  • B細胞慢性リンパ性白血病の治療薬の治験に参加している上位企業

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Celgene Corporation
    • Sanofi
    • AbbVie Inc.
    • Pharmacyclics, Inc.
    • Merck & Co., Inc.
    • German CLL Study Group
    • Biogen Idec Inc.
    • Amgen Inc.
    • Bayer AG
  • 代表的な病院・研究機関の治験の概要
    • National Cancer Institute
    • Fred Hutchinson Cancer Research Center
    • Baylor College of Medicine
    • Mayo Clinic
    • The University of Texas M. D. Anderson Cancer Center
    • Eastern Cooperative Oncology Group
    • North Central Cancer Treatment Group
    • Southwest Oncology Group
    • Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS
    • North Shore Long Island Jewish Health System

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC3497CTIDB

GlobalData's clinical trial report, "B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Chronic Lymphocytic Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Chronic Lymphocytic Leukemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Five Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of B-Cell Chronic Lymphocytic Leukemia to Oncology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of B-Cell Chronic Lymphocytic Leukemia to Oncology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 262

  • Abbreviations 262
  • Definitions 262
  • Research Methodology 263
  • Secondary Research 263
  • About GlobalData 264
  • Contact Us 264
  • Disclaimer 264
  • Source 265

List of Tables

List of Tables

  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
  • Proportion of B-Cell Chronic Lymphocytic Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 14
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of B-Cell Chronic Lymphocytic Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 17
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28

List of Figures

List of Figures

  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
  • Proportion of B-Cell Chronic Lymphocytic Leukemia to Oncology Clinical Trials, G7 Countries (%), 2016* 14
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of B-Cell Chronic Lymphocytic Leukemia to Oncology Clinical Trials, E7 Countries (%), 2016* 17
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • B-Cell Chronic Lymphocytic Leukemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28
  • GlobalData Methodology 263
Back to Top